
Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy
Cell and gene therapies (CGTs) are quickly moving to the forefront of specialty pharmacy and have become central to the future of pharmaceutical innovation, according to a panel discussion held during a business session titled “Cell, Gene and Beyond: What’ …